Get to know 15 of the best biotech companies in Paris
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…
Since the approval of the first gene therapy for blindness, there has been a wave…
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
The French biotech GenSight will apply for regulatory approval for its gene therapy despite the…
GenSight has demonstrated that its gene therapy for a rare disease causing blindness can significantly…
The results of a long-term follow-up suggest that GenSight's gene therapy for Leber hereditary optic…
GenSight will start a clinical trial in the UK testing a combination of gene therapy…
As the 2017 reports roll in, we're already turning our gaze to 2018. These are…
Now that we've got the bad news out of the way, we're here to spread…
Update (05/12/2017): GenSight has reported a sustained effect of its treatment GS010, which has now…
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix…
Gensight Biologics has announced a capital increase that totals €22.5M and will support the launch…